AGUIAR ERIC
Transactions
50
Companies
9
Filings
14
CIK
0001262325
Recent Transactions
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Sale
- Exercise/Conversion
- Sale
- Exercise/Conversion
- Exercise/Conversion
- Exercise/Conversion
- Sale
- Sale
- Exercise/Conversion
- Exercise/Conversion
- Exercise/Conversion
- Exercise/Conversion
- Sale
- Sale
- Exercise/Conversion
- Award
- Award
- Exercise/Conversion
- Award
- Exercise/Conversion
- Exercise/Conversion
Employee Stock Option (Right to Buy)
2020-01-22−771→ 22,500 total - Sale
- Sale
- Exercise/Conversion
Employee Stock Option (Right to Buy)
2020-01-22−1,250→ 2,500 total - Sale
- Sale
Companies
9Biohaven Pharmaceutical Holding Co Ltd.
Director
- $BMEA
Biomea Fusion, Inc.
Director
- $BBIO
BridgeBio Pharma, Inc.
Director
Cardiovascular Systems Inc
10% Owner
CORNERSTONE THERAPEUTICS INC
10% Owner
Eidos Therapeutics, Inc.
Director
Invitae Corp
Director
MiddleBrook Pharmaceuticals, Inc.
10% Owner
Ocera Therapeutics, Inc.
10% Owner
Recent Filings
14- 4
AGUIAR ERIC
Jun 24, 2026
- 4
AGUIAR ERIC
Jun 12, 2026
- 4
AGUIAR ERIC
Jun 24, 2025
- 4
AGUIAR ERIC
Jun 13, 2025
- 4
AGUIAR ERIC
Jun 25, 2024
- 4
AGUIAR ERIC
Jun 13, 2024
- 4
AGUIAR ERIC
Jun 23, 2023
- 4
AGUIAR ERIC
Jun 16, 2023
- 4
AGUIAR ERIC
May 1, 2023
- 4
AGUIAR ERIC
Jun 24, 2022
- 4
AGUIAR ERIC
Jun 24, 2022
- 4
AGUIAR ERIC
May 2, 2022
- 4
AGUIAR ERIC
Jun 22, 2021
- 4
AGUIAR ERIC
May 4, 2021
Address
C/O BRIDGEBIO PHARMA, INC. 3160 PORTER DR., SUITE 250
PALO ALTO, CA, 94304